指南与共识儿科与产科急症

新生儿B族链球菌早发型疾病的预防:ACOG委员会意见摘要第797号

Prevention of Group B Streptococcal Early-Onset Disease in Newborns: ACOG Committee Opinion Summary, Number 797.
指南 / 共识 · Obstet Gynecol · 2020-01-01
一句话结论ACOG推荐在妊娠36 0/7至37 6/7周普遍筛查GBS,阳性者产时抗生素预防,除非完整胎膜下计划剖宫产。

B族链球菌是新生儿感染的首要原因,母婴垂直传播主要发生在产程或破膜后。ACOG委员会意见第797号推荐在妊娠36 0/7至37 6/7周进行普遍阴道-直肠培养筛查,阳性孕妇应接受产时抗生素预防,除非在完整胎膜下行计划剖宫产。产时抗生素预防短于4小时效果低于4小时或以上,但2小时暴露已显示可减少GBS阴道菌落计数和新生儿临床脓毒症诊断频率。产科干预不应仅为了完成4小时抗生素给药而延迟。该意见更新并替代CDC 2010指南的产科部分。

要点

  • ACOG推荐所有孕妇在妊娠36 0/7至37 6/7周进行普遍GBS阴道-直肠培养筛查。
  • 筛查阳性孕妇应接受产时抗生素预防,除非在完整胎膜下行计划剖宫产。
  • 产时抗生素预防短于4小时效果低于4小时或以上,但2小时暴露可减少GBS阴道菌落计数和新生儿临床脓毒症诊断频率。
  • 产科干预不应仅为了提供4小时抗生素给药而延迟。
  • 其他早发型疾病危险因素包括胎龄小于37周、极低出生体重、破膜延长、羊膜腔内感染、年轻母亲年龄和母亲黑人种族。

适用人群与场景

  • 所有孕妇应在妊娠36 0/7至37 6/7周进行普遍GBS筛查。
  • 筛查阳性孕妇应接受产时抗生素预防,除非在完整胎膜下行计划剖宫产。

诊断标准与关键阈值

  • 普遍产前筛查采用阴道-直肠培养,在妊娠36 0/7至37 6/7周进行。
  • 新生儿GBS早发型疾病的其他危险因素包括胎龄小于37周、极低出生体重、破膜延长、羊膜腔内感染、年轻母亲年龄和母亲黑人种族。

处置流程与药物剂量

  • 所有妊娠36 0/7至37 6/7周阴道-直肠培养GBS阳性的孕妇应接受适当的产时抗生素预防,除非在完整胎膜下行计划剖宫产。
  • 产时抗生素预防短于4小时效果低于4小时或以上,但2小时抗生素暴露已显示可减少GBS阴道菌落计数和降低新生儿临床脓毒症诊断频率。
  • 产科干预不应仅为了提供4小时抗生素给药而延迟。

研究设计与关键结果

  • 约50%的GBS定植孕妇会将细菌传播给新生儿。
  • 无产时抗生素预防时,1-2%的这些新生儿会发展为GBS早发型疾病。

证据类型、等级与局限

  • 证据类型:ACOG委员会意见(指南)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • ACOG推荐在妊娠36 0/7至37 6/7周进行普遍GBS筛查,取代既往筛查时机。
  • 筛查阳性孕妇应接受产时抗生素预防,除非在完整胎膜下行计划剖宫产。
  • 不应仅为了完成4小时抗生素给药而延迟必要的产科干预。

指南或共识出处

  • ACOG委员会意见第797号,更新并替代CDC 2010指南「Prevention of Perinatal Group B Streptococcal Disease: Revised Guidelines From CDC, 2010」的产科部分。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

Group B streptococcus (GBS) is the leading cause of newborn infection. The primary risk factor for neonatal GBS early-onset disease (EOD) is maternal colonization of the genitourinary and gastrointestinal tracts. Approximately 50% of women who are colonized with GBS will transmit the bacteria to their newborns. Vertical transmission usually occurs during labor or after rupture of membranes. In the absence of intrapartum antibiotic prophylaxis, 1-2% of those newborns will develop GBS EOD. Other risk factors include gestational age of less than 37 weeks, very low birth weight, prolonged rupture of membranes, intraamniotic infection, young maternal age, and maternal black race. The key obstetric measures necessary for effective prevention of GBS EOD continue to include universal prenatal screening by vaginal-rectal culture, correct specimen collection and processing, appropriate implementation of intrapartum antibiotic prophylaxis, and coordination with pediatric care providers. The American College of Obstetricians and Gynecologists now recommends performing universal GBS screening between 36 0/7 and 37 6/7 weeks of gestation. All women whose vaginal-rectal cultures at 36 0/7-37 6/7 weeks of gestation are positive for GBS should receive appropriate intrapartum antibiotic prophylaxis unless a prelabor cesarean birth is performed in the setting of intact membranes. Although a shorter duration of recommended intrapartum antibiotics is less effective than 4 or more hours of prophylaxis, 2 hours of antibiotic exposure has been shown to reduce GBS vaginal colony counts and decrease the frequency of a clinical neonatal sepsis diagnosis. Obstetric interventions, when necessary, should not be delayed solely to provide 4 hours of antibiotic administration before birth. This Committee Opinion, including Table 1, Box 2, and Figures 1-3, updates and replaces the obstetric components of the CDC 2010 guidelines, "Prevention of Perinatal Group B Streptococcal Disease: Revised Guidelines From CDC, 2010."

来源:Obstet Gynecol,查看原文。版权归原作者所有。

参考来源

  1. Prevention of Group B Streptococcal Early-Onset Disease in Newborns: ACOG Committee Opinion Summary, Number 797. Obstet Gynecol. 2020. PMID: 31977793. doi:10.1097/AOG.0000000000003669

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。